Asia-Pacific PDX models market is projected to register a CAGR of 17.9% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Asia-Pacific PDX Models Market By Type (Mice Models, Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models, Others), Application (Preclinical Drug Development, Precision Medicine, Co-clinical Trials, Basic Cancer Research, Biomarker Analysis), Technique (Heterotopic Implantation & Orthotropic Implantation), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Organizations & Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific PDX models market are:

• Wide adoption of PDX models in pre-clinical research
• Increase in demand of personalized medicine

Market Players:

The key market players for Asia-Pacific PDX models market are listed below:

• Crown Bioscience Inc.
• The Jackson LaboratoryC
• hampions Oncology, Inc.
• Charles River Laboratories
• Wuxi AppTec
• Oncodesign
• Biocytogen
• Bioduro
• Covance Inc.
• Horizon Discovery Ltd.
• Pharmatest Services